Roflumilast improved FEV 1 by 48 ml ... [78] There were 22 sudden cardiac deaths linked to azithromycin. Daily azithromycin use to prevent COPD exacerbations may not be appropriate in every ...
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.
Consider roflumilast to reduce COPD-related exacerbations ... 60% predicted and who fails to qualify for omalizumab, consider azithromycin in addition to the lowest effective dose of prednisone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results